» Services Client Login | Email | Phone: 1.865.380.9746



MPLN's testing process delivers the right actionable results on-time using the latest technologies and biomarkers to support clinicians in delivering personalized patient care.

We offer comprehensive testing as well as consultative services and a streamlined approach to laboratory medicine to meet drug discovery, diagnostic, and prognostic challenges in a timely, cost-effective manner. 

Diagnostic and Genomic Services

Molecular Pathology Laboratory Network, Inc., (MPLN) a premiere diagnostic laboratory based in the Southeastern United States, offers an expanding selection of molecular diagnostics, flow cytometry, cytogenetic tests, and many other advanced services for oncology, pathology, women's health diagnosis, and clinical trials. MPLN practices evidence based, precise, and predictable diagnostics for individual patient management to improve patient outcome and reduce cost of care. MPLN's streamlined approach to laboratory medicine meets diagnostic and prognostic challenges in a timely, cost-effective manner.

The Difference Is Experience

MPLN is a leader in the implementation of patient-specific reflex testing (StrataFLEX) that strategically moves clinicians through the laboratory process, addressing each stage of patient management in a consultative, timely, and cost-effective manner. MPLN's board-certified pathologists and scientific directors provide consultative services in oncology, hematopathology, and women's health.

Comprehensive, Personalized Testing Services

MPLN is dedicated to providing superior diagnostic services to our clients in pathology groups, hospitals, medical laboratories, and physician groups nationwide. With a patient-focused approach, we honor an obligation to provide:

  • High-quality, timely results
  • Cost-effective testing strategies
  • Personalized consultative testing services
  • Responsive and professional customer service

Contract Services

Geneuity Clinical Research Services (CRS) is MPLN's provider of molecular and cellular testing for preclinical through phase III and post market surveillance as well as assay and companion diagnostic development and validation.

Partner Programs

MPLN can assist oncology and pathology groups, clinical laboratories, and hospitals in readiness for health care changes.

Geneuity CRS also can assist both medical device companies and drug discovery by providing services and access to high complexity testing, platform, and assay validation of biomarkers or companion diagnostics, patient screening for clinical trial selection, and recuitment and clinical trial testing in a CLIA regulated, CAP accredited, and GxP compliant medical laboratory setting.

Testing Resources

MPLN's Oncology Test Menu

MPLN's Pathology Menu

MPLN's Women's Health Menu